Amelioration of stroke-induced neurological deficiency by lyophilized powder of catapol and puerarin

International Journal of Biological Sciences

Volumn 10, Issue 4, 2014, Pages 448-456

  Liu, Yang ^a,b   Xue, Qiang ^a,b   Li, Xu ^a,b   Zhang, Jifen ^a,b   Fu, Zhifeng ^a   Feng, Binbin ^c   Chen, Yi ^a,b   Xu, Xiaoyu ^a,b  

^a SOUTHWEST UNIVERSITY   (China)

^b Chongqing Center for Pharmacodynamics Research and Evaluation   (China)

^c Chongqing Three Gorges Medicine College   (China)

Author keywords

Catapol; Neurological function; Puerarin; Stroke

Indexed keywords

CATAMINE AB; ISOFLAVONE DERIVATIVE; POWDER; PUERARIN; QUATERNARY AMMONIUM DERIVATIVE;

ANGIOGENESIS; ANIMAL; APOPTOSIS; DRUG EFFECTS; FREEZE DRYING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; OXIDATIVE STRESS; PC12 CELL LINE; POWDER; RAT; STROKE; THERAPEUTIC USE;

ANIMALS; APOPTOSIS; FREEZE DRYING; IMMUNOHISTOCHEMISTRY; ISOFLAVONES; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS; OXIDATIVE STRESS; PC12 CELLS; POWDERS; QUATERNARY AMMONIUM COMPOUNDS; RATS; STROKE;

EID: 84898453041     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.8571     Document Type: Article

References (54)

1. Diener HC, Katsarava Z, Weimar C. Headache associated with ischemiccere-brovascular disease. Rev. Neurol. (Paris). 2008; 164 (10): 819-824.
2. Candelario-Jalil E. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Current opinion in investigational drugs (London, England: 2000), 2009; 10(7):644-654.
3. Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996; 27(6): 1124-1129.
4. Ohab JJ, Fleming SA, et al. Carmichael. A neurovascular niche for neurogenesis after stroke. The Journal of neuroscience. 2006; 26(50): 13007-13016.
5. Harold P, et al. Guidelines for the early management of patients with ischemic stroke a scientific statement from the stroke council of the american stroke association. Stroke. 2003;(34):1056-1083.
6. Li DQ, Li Y, Liu Y, et al. Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion in-jury. Toxicon. 2005; 46(8): 845-851.
7. Zhu. Hf, Wan D, Luo. YP, et al. Catalpol up-regulated GAP-43 protein expression and improved behavior outcome of focal cerebral ischemia rats. Chinese Pharmacological Bulletin. 2007; 23(9): 1231.
8. Zhu HF, Wan D, Luo Y, et al. Catalpol increases brain angiogenesis and up-regulates VEGF and EPO in the rat after permanent middle cerebral artery occlusion. International journal of biological sciences. 2010; 6(5): 443-453.
9. Jiang B, Liu J, et al. Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome i> c release and inactivating of caspase cascade. Toxicon. 2004; 43(1): 53-59.
10. Bi J, Jiang B, Hao S, Zhang A, et al. Catalpol attenuates nitric oxide increase via ERK signaling pathways induced by rotenone in mesencephalic neurons. Neurochemistry international. 2009; 54(3): 264-270.
11. Li Y, Pan W, Chen S, Xu HD, et al. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats. Drug development and industrial pharmacy. 2006; 32(4): 413-422.
12. Chang Y, et al. Neuroprotective mechanisms of puerarin in middle cerebralartery occlusion-induced brain infarct in rats. J Biomed Sci. 2009; 16(9): 1-13.
13. Xu X, et al. The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta medica, 2005; 71(7): 585.
14. Wan H, et al. Protective effect of chuanxiongzine-puerarin in a rat model of ransient middle cerebral artery occlusion-induced focal cerebral ischemia. Nuclear medicine communications, 2008; 29(12): 1113-1122.
15. Liu CM, et al. Puerarin protects the rat liver against oxidative stress-mediated DNA damage and apoptosis induced by lead. Experimental and Toxicologic Pathology, 2012; 64(6):575-582.
16. Tang XL, et al. Dynamic Oxidative Stress and DNA Damage Induced by Oestrogen Deficiency and Protective Effects of Puerarin and 17βOestradiol in Ovariectomized Rats. Basic & clinical pharmacology & toxicology, 2012;111(2):87-91.
17. Fisher M. New approaches to neuroprotective drug development. Stroke, 2011; 42(1 suppl 1): 24-27.
18. Yuan HH, Zhang JF, Wang Q, Deng LJ, Xu XY. Focal irritant, allergia, hae-molyticus and acute toxicity of Catalpol and Puerarin for injection. Chinese Pharmacological Bulletin. 2013; 29(6): 880-881
19. Yuan HH, et al. Determination of Catalpol and Puerarin Contents and Their Related Substances in Zige Freeze-Dried Powder for Injection by RP-HPLC. Chinese Pharmaceutical Journal 2011; 16: 020.
20. Wang Q, Xing M, Deng L, et al. Distribution of puerarin contained in zige freeze-dried powder injection in rat liver and kid-ney. China journal of Chinese materia medica. 2012; 37(11): 1677.
21. Deng L, Wang Q, Yuan H, et al. Effect of catalpol and puerarin freeze-dried powder on coagulability, hemorheology and no in rats with Qi-deficiency and blood-stasis syndrome. China journal of Chinese materia medica. 2012; 37(10): 1472.
22. Zhang C, Ma Q, Xue Q, et al. Protective effect of Zige lyophilized powder on hypoxia/reoxygenation injury of human umbilical vein endothelial cells. China journal of Chinese materia medica. 2012;37(7):997.
23. Longa EZ, Weinstein PR, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1): 84-91.
24. Wang GL. and Semenza G. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. Journal of Biological Chemistry.1993;268(29): 21513-21518.
25. Petullo D, Masonic K, Lincoln C, Wibberley L, et al. Model development and behavioral assessment of focal cerebral ischemia in rats. Life sciences. 1999;64(13): 1099-1108.
26. Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001; 32(11): 2682-2688.
27. Bederson J, Pitts L, Germano S, Nishimura M, Davis R, Bartkowski H. Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986; 17: 1304-1308.
28. Ito U, Ohno K, Nakamura R, et al. Brain edema during ischemia and after restoration of blood flow. Measurement of water, sodium, potassium content and plasma protein permeability. Stroke. 1979; 10(5): 542-547.
29. Ronen R, et al. Long-Lasting Regeneration after Ischemia in the Cerebral Cortex. Stroke.2007; 38:153-161.
30. Lixin Sun, Jeongwu Lee and Howard Fine A. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest. 2004; 113(9):1364-1374
31. Weidner N, Semple JP, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New England Journal of Medicine. 1991; 324(1): 1-8.
32. Q Xue, et al. A Novel Brain Neurovascular Unit Model with Neurons, Astro cytes and Microvascular Endothelial Cells of Rat. Int J Bio Sci. 2013; 9(2):174-189.
33. Dirnagl U, et al. Pathobiology of ischaemic stroke: an integrated view. Trends in neurosciences. 1999; 22(9): 391-397.
34. O'Collins V.E, et al. Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experi-mental testing. Journal of Cerebral Blood Flow & Metabolism, 2011;31(3):962-975.
35. Barabási, AL, Gulbahce N, and Loscalzo J. Network medicine: a net-work-based approach to human disease. Nature Reviews Genetics, 2011;12(1):56-68.
36. Gladstone DJ, et al. Toward wisdom from failure lessons from neuroprotective stroke trials and new therapeutic directions. Stroke, 2002; 33(8):2123-2136.
37. Scheidtmann K, et al. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, dou-ble-blind study. The Lancet, 2001; 358(9284): 787-790.
38. Gaur V, and Kumar A. Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction. Inflammopharmacology, 2011; 19(4):205-214.
39. Culmsee C, et al. Combination therapy in ischemic stroke: synergistic neuro-protective effects of memantine and clenbuterol. Stroke, 2004;35(5): 1197-1202.
40. Atif F, et al. Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection. Neuropharmacology, 2013; 67:78-87.
41. Zhang L, et al. Combination Treatment With N-Acetyl-Seryl-Aspartyl-Lysyl-Proline and Tissue Plasminogen Activator Provides Potent Neuroprotection in Rats After Stroke. Stroke, 2014; STROKEAHA. 113.004399.
42. Gong X, and Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends in pharmacological sciences, 1999; 20(5):191-196.
43. Wang L, et al. Dissection of mechanisms of Chinese medicinal formula Real-gar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proceedings of the National Academy of Sciences, 2008; 105(12):4826-4831.
44. Tang Q, et al. Combination use of ferulic acid, ligustrazine and tetra-hy-dropalmatine inhibits the growth of ectopic endometrial tissue: A multi-target therapy for endometriosis rats. Journal of ethnopharmacology, 2014.
45. LIU M, et al. Catalpol up-regulated NGF, BDNF and mRNA gene expression and improved behavior outcome of rats with ischemic stroke. China Journal of Traditional Chinese Medicine and Pharmacy, 2011; 5: 022.
46. Ming L, et al. Effect of catalpol on brain energy metabolism in rats with permanent cerebral ischemia injury [J]. Pharmacology and Clinics of Chinese Materia Medica, 2010; 5: 019.
47. Hu L, Sun Y, and Hu J. Catalpol inhibits apoptosis in hydrogen perox-ide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax. European journal of pharmacology, 2010; 628(1):155-163.
48. Chen W, et al. Neuroprotective activities of catalpol against CaMKII dependent apoptosis induced by LPS in PC12 cells. British journal of pharmacology, 2013; 169(5): 1140-1152.
49. Tan Y, Liu M, and Wu B. Puerarin for acute ischemic stroke. Stroke, 2008; 39(7): 2188-2188.
50. Hu H, Fen F, and Ding M. Effects of puerarin with aspirin on the markers of damaged vascular endothelial cells in patients with acute cerebral infarction]. China journal of Chinese materia medica, 2008; 33(23):2827-2829.
51. Jiang B, et al. Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin. Cell Biology International, 2003; 27(12):1025-1031.
52. Kim J, et al. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH ox-idase-related oxidative stress. Free Radical Biology and Medicine, 2012; 53(2):357-365.
53. Shi R, and Zhang J. Protective effect of puerarin on vascular endothelial cell apoptosis induced by chemical hypoxia in vitro]. Acta pharmaceutica Sinica, 2003; 38(2):103.
54. Zhang S, et al. Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. Biological and Pharmaceutical Bulletin, 2006; 29(5):945.